Cannabis stocks – struggling to get high

Cannabis stocks – struggling to get high
Greenfern will soon start writing clinical trial protocols for a low dose cannabidiol medication. (Image: Getty)
Brian Gaynor
The three NZX-listed cannabis companies – Cannasouth, Greenfern Industries and Rua Bioscience – are struggling to gain momentum, particularly as far as their share price performances are concerned.All three stocks are trading well below their issue price.This will be a major disappointment to Sharesies investors because they have dominated trading activity in all three companies.Sharesies investors make up 61% of all Cannasouth on-market trades by number since listing, 70.5% of Greenfern’s trades, and 64.3% of Rua Bioscience&r...

More Opinion

Bulls, bears and analysis …
Opinion

Simon Robertson: Bulls, bears and analysis …

Why price-to-earnings ratios don’t cut it.

Simon Robertson 15 Nov 2025
What employers can learn from the BBC scandal
Opinion

Rachael Judge: What employers can learn from the BBC scandal

Organisations should handle protected disclosures in a fair and just manner.

Rachael Judge 14 Nov 2025
Vital pays the price of shedding Toronto flu
Opinion Stock & Trade

Stock & Trade: Vital pays the price of shedding Toronto flu

Costly clean-up comes with some fishhooks but largely positive for unitholders.

Stock & Trade 14 Nov 2025